Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B‐cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|36|1|68-75

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 68-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas

By Stroppa Elisa   Bertuzzi Alexia   Comite Gabriele   Mussi Chiara   Lutman Romano   Barbato Alfredo   Santoro Armando  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 834-838

Springer Publishing Company

Access to resources Recommend Favorite

Novel agents for diffuse large B-cell lymphoma

By Sinha Rajni   DeJoubner Nutan   Flowers Christopher  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 669-680

Informa Healthcare

Access to resources Recommend Favorite

Combination of rituximab and nonpegylated liposomal doxorubicin (R‐NPLD) as front‐line therapy for aggressive non‐Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single‐center retrospective study

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 44-48

John Wiley & Sons Inc

Access to resources Recommend Favorite

Age-related differences in quality of life among patients with diffuse large B-cell lymphoma

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2857-2858

Blackwell Publishing

Access to resources Recommend Favorite

Reply to age-related differences in quality of life among patients with diffuse large B-cell lymphoma

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2858-2859

Blackwell Publishing

Access to resources Recommend Favorite